Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
As healthcare providers seek to optimize patient outcomes in metabolic disease management, understanding the mechanisms behind combination therapies becomes essential
No single prescription weight-loss drug is best for everyone, since the right option depends on health history and body weight
(Malhotra et al
[110] Exenatide, the first of the GLP-1 receptor agonists, was approved by the US Food and Drug Administration in April 2005
It reduces appetite by targeting brain areas that control hunger, slows gastric emptying to extend feelings of fullness, and improves insulin sensitivity
Dao et al., 2016
US$ 29.38
US$ 23.08
US$ 21.85
